Topic

Natpara (parathyroid hormone)

A collection of 13 issues

The Requirements Checklist to Get Natpara (Parathyroid Hormone) Covered by Aetna (CVS Health) in California

Quick Answer: Getting Natpara (parathyroid hormone) covered by Aetna (CVS Health) in California requires prior authorization with strict clinical documentation. You'll need confirmed hypoparathyroidism diagnosis, failed calcium/vitamin D therapy records, and endocrinologist support. Important: Takeda discontinued Natpara manufacturing globally in late 2024, with U.S. supply ending

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Virginia: Complete Requirements Guide and Appeals Process

Answer Box: Getting Natpara Covered by Blue Cross Blue Shield in Virginia Natpara (parathyroid hormone) requires prior authorization from Blue Cross Blue Shield Virginia plans. However, Takeda discontinued global manufacturing in 2024, with U.S. supply ending December 31, 2025. New starts are typically denied due to lack of commercial

How to Get Natpara (Parathyroid Hormone) Covered by UnitedHealthcare in Pennsylvania: 2025 Discontinuation Guide

Quick Answer: Natpara Coverage Status in Pennsylvania Natpara (parathyroid hormone) is being discontinued globally by Takeda as of December 31, 2024. UnitedHealthcare in Pennsylvania will only cover existing patients through December 2025, with no new patient starts allowed. If you're currently on Natpara, work with your endocrinologist immediately

The Requirements Checklist to Get Natpara (Parathyroid Hormone) Covered by Humana in Michigan

Quick Answer: Getting Natpara covered by Humana in Michigan requires prior authorization through CenterWell Specialty Pharmacy, documented failure of calcium/vitamin D therapy, and specialist consultation. Submit requests via Availity Essentials or call 800-523-0023. If denied, you have 65 days to appeal and can request external review through Michigan DIFS

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Washington: Appeals Guide with Forms and Deadlines

Quick Answer: Getting Natpara Covered by Blue Cross Blue Shield in Washington Important: Natpara is being discontinued globally, with U.S. shipments ending December 31, 2025. New patient approvals are extremely rare due to supply cessation. For existing patients or those seeking alternatives, here's your fastest path: 1.

Myths vs. Facts: Getting Natpara (Parathyroid Hormone) Covered by UnitedHealthcare in New York

Answer Box: The Reality of Natpara Coverage in New York Myth-Busting Summary: Natpara (parathyroid hormone) is being discontinued by Takeda, with all U.S. shipments ending December 31, 2025. UnitedHealthcare is not approving new patients for Natpara, only maintaining existing Special Use Program enrollees. New York residents facing denials should

Renewing Natpara (Parathyroid Hormone) Coverage with UnitedHealthcare in Ohio: Complete 2025 Guide

Answer Box: Renewing Natpara Coverage in Ohio UnitedHealthcare requires annual reauthorization for Natpara (parathyroid hormone) with specific documentation. Start your renewal 60-90 days before expiration. You'll need: recent serum calcium labs (8.0-8.5 mg/dL target), continued calcium supplementation proof, and specialist prescription from endocrinologist/nephrologist. Submit

How Long Does It Take to Get Natpara (Parathyroid Hormone) Approved by Aetna CVS Health in Virginia? Timeline & Appeal Guide

Quick Answer: Natpara (parathyroid hormone) is currently unavailable for new prescriptions through Aetna CVS Health as Takeda discontinued manufacturing in 2024. Existing patients on the Special Use Program have access until December 31, 2025. For hypoparathyroidism treatment, work with your endocrinologist to request formulary exceptions for alternative therapies like high-dose

How to Get Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Illinois: Complete 2025 Guide

Quick Answer: Getting Natpara Covered by Aetna CVS Health in Illinois Important Update: Takeda discontinued Natpara manufacturing globally at the end of 2024, with U.S. Special Use Program shipments ending December 31, 2025. New starts are typically denied due to lack of commercial supply. Only existing patients enrolled in

Natpara (Parathyroid Hormone) Approval with Aetna CVS Health in North Carolina: Complete Coverage Guide

Quick Answer: Getting Natpara Covered by Aetna CVS Health in North Carolina Critical Update: Takeda has permanently discontinued Natpara manufacturing. The U.S. Special Use Program ends December 31, 2025, with no further shipments available. Patients must transition to alternative therapies before this deadline. For existing patients or those seeking